Convergence Investment Partners LLC Makes New $447,000 Investment in Option Care Health, Inc. $OPCH

Convergence Investment Partners LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,768 shares of the company’s stock, valued at approximately $447,000.

Several other large investors also recently bought and sold shares of OPCH. GAMMA Investing LLC increased its holdings in Option Care Health by 307.1% during the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock worth $112,000 after purchasing an additional 2,408 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock worth $289,000 after purchasing an additional 1,691 shares during the period. Bessemer Group Inc. increased its holdings in Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after purchasing an additional 599 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in Option Care Health by 6,525,926.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company’s stock worth $52,459,000 after purchasing an additional 1,500,963 shares during the period. Finally, Teacher Retirement System of Texas increased its holdings in Option Care Health by 73.0% during the 1st quarter. Teacher Retirement System of Texas now owns 107,644 shares of the company’s stock worth $3,762,000 after purchasing an additional 45,431 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In related news, Director Norman L. Wright acquired 3,411 shares of the firm’s stock in a transaction on Tuesday, September 9th. The stock was bought at an average cost of $29.31 per share, with a total value of $99,976.41. Following the transaction, the director owned 15,501 shares of the company’s stock, valued at $454,334.31. The trade was a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Timothy P. Sullivan acquired 20,000 shares of the firm’s stock in a transaction on Thursday, August 21st. The shares were bought at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the transaction, the director directly owned 49,229 shares in the company, valued at $1,354,289.79. This trade represents a 68.43% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 59,411 shares of company stock valued at $1,627,576 in the last three months. 0.64% of the stock is currently owned by company insiders.

Option Care Health Stock Down 0.3%

Shares of NASDAQ OPCH opened at $27.84 on Tuesday. The stock has a market cap of $4.52 billion, a PE ratio of 22.27, a price-to-earnings-growth ratio of 1.69 and a beta of 0.88. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The business has a 50-day moving average price of $27.99 and a 200 day moving average price of $30.03.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business’s revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analyst Weigh In

OPCH has been the topic of several recent research reports. JMP Securities upped their price target on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a report on Thursday, July 31st. TD Cowen assumed coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating and a $30.00 price objective for the company. Morgan Stanley assumed coverage on Option Care Health in a research report on Friday, October 17th. They set an “overweight” rating and a $35.00 price objective for the company. Cowen assumed coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating for the company. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Tuesday, September 23rd. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.10.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.